A Phase 1/2 interventional study of Transcranial magnetic stimulation in Scrotal Pain, sponsored by Medical University of South Carolina. Withdrawn at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Medical University of South Carolina · Phase 1/2, Interventional, and Treatment
Study discontinued before starting
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Pain by Medical University of South Carolina — 3 open to participants now, 3 under way, none of them phase 3. Pain · Medical University of South Carolina.
Among the 15 studies in Pain by Medical University of South Carolina, this one is the 13th largest by enrollment, is one of 3 that started in 2026, is the only one in phase 1/2, and was the 13th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →3 of the 15 studies in Pain by Medical University of South Carolina are open now, in 1 country. Recruiting first, the newest first:
Medical University of South Carolina · Sites in United States
Ages 18–80
Medical University of South Carolina · Sites in United States
Ages 18+ · Women only
Medical University of South Carolina · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 1
First in 2005; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 15 across the 15 interventional studies. Of the 9 that completed or were terminated, 7 (78%) have results posted.
This tab as a report to print or save as PDF → With an account.
Medical University of South Carolina is the lead sponsor of 875 studies on the registry; 165 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.
3 of the studies in Pain by Medical University of South Carolina that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05492188Medical University of South CarolinaNeuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI | 2027-01-15 |
| NCT07144436Medical University of South CarolinaPost-stroke Pain tAN-fMRI | 2027-06-30 |
| NCT06991075Medical University of South CarolinaTranscutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Pain by Medical University of South Carolina, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to perform an open label feasibility trial of TMS for the treatment of chronic scrotal content pain.
The purpose of this study is to perform an open label feasibility trial of TMS for the treatment of chronic scrotal content pain. Participants will be screened by study staff for contraindications to TMS treatment. TMS will be delivered use the MagVenture TMS machine. TMS will be delivered during 15 minutes per session, 3 sessions each day, for 3 days. A custom developed SMS text EMA system will be used to gather daily data on pain and functioning in study participants.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Open label study. Participants will be screened by study staff for contraindications to TMS treatment. TMS will be delivered use the MagVenture TMS machine.
Other: Transcranial magnetic stimulation
Resting motor threshold will be established by first finding the area of the motor cortex associated with visible twitch of the right abductor pollicis brevis (APB). Parameter Estimation by Sequential Testing (PEST) will be conducted to quantify resting motor threshold using visible APB twitch. The left dorsolateral prefrontal cortex (DLPFC) will be located using the Beam F3 method and marked with a felt-tipped marker on the scalp. TMS will be delivered over left DLPFC at 110% of resting motor threshold at 10Hz (5-seconds-on; 10-seconds-off) for 15 minutes per session (3000 pulses), 3 sessions each day (30-minute rest in-between sessions), for 3 days (within 5 consecutive days; a total of 27,000 pulses).
Patient reported pain score on SMS text EMA system
A custom developed SMS text EMA system will be used to gather daily data on pain
Time frame: baseline, and post intervention (0 days, 1 week, 2 weeks, 1 month, 3 months, 6 months)
Patient reported post procedure quality of life as measured on an SMS text EMA system
A custom developed SMS text EMA system will be used to gather daily data on pain
Time frame: baseline, and post intervention (0 days, 1 week, 2 weeks, 1 month, 3 months, 6 months)
Progression to other treatments
Progression to other medical or surgical treatments
Time frame: Within 6 months after completion
Plan to share: No — Based on internal IRB submission, IPD will not be shared
Ran from Sep 2026 to primary completion in Sep 2026, 0 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion Apr 2030 → Sep 2026 and completion Apr 2030 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Study discontinued before starting
Study discontinued before starting
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is withdrawn, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of South Carolina →